25173-35-7

Basic information

• Product Name: 2-METHOXYHYDROCINNAMIC ACID
• Synonyms: 3-(O-METHOXYPHENYL)PROPIONIC ACID 97%;3-(2-Methylphenoxy)propionic Acid;3-(2-methylphenoxy)propanoic acid(SALTDATA: FREE);2-Methylphenoxy-beta-propionic acid;3-(2-Methylphenoxy)propanoic acid;3-(2-Tolyloxy)propionic acid
• CAS NO: 25173-35-7
• Molecular Formula: C₁₀H₁₂O₃
• Molecular Weight: 180.21
• Mol File: 25173-35-7.mol
• Article Data: 6

Chemical Properties

• Melting Point: 94-95℃
• Boiling Point: 285℃
• Flash Point: 110℃
• Appearance: /
• Density: 1.145
• Vapor Pressure: 0.00133mmHg at 25°C
• Refractive Index: 1.529
• Storage Temp.: 2-8°C
• PKA: 4.22±0.10(Predicted)
• CAS DataBase Reference: 2-METHOXYHYDROCINNAMIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2-METHOXYHYDROCINNAMIC ACID(25173-35-7)
• EPA Substance Registry System: 2-METHOXYHYDROCINNAMIC ACID(25173-35-7)

Safety Data

• Hazardous Substances Data: 25173-35-7(Hazardous Substances Data)

Usage

General Description

2-Methoxyhydrocinnamic acid, also known as ferulic acid, is a naturally occurring organic compound found in various plants. It is a phenolic acid with antioxidant properties and is often used in skincare products and as a food additive due to its ability to preserve and stabilize ingredients. It is also known for its potential antimicrobial and anti-inflammatory properties, making it useful for treating various skin conditions and reducing the effects of aging. Additionally, 2-methoxyhydrocinnamic acid has been studied for its potential health benefits, including its ability to protect against cardiovascular disease and cancer. Overall, this chemical compound has a wide range of applications in the cosmetic, pharmaceutical, and food industries.

InChI:InChI=1/C10H12O3/c1-8-4-2-3-5-9(8)13-7-6-10(11)12/h2-5H,6-7H2,1H3,(H,11,12)

Upstream product

• 57-57-8 β-Propiolactone 
• 4549-72-8 sodium o-cresolate 
• 25268-05-7 3-(2-methylphenoxy)propanenitrile 
• 107-94-8 chloropropionic acid 
• 95-48-7 ortho-cresol 
• 107-13-1 acrylonitrile 

Downstream Products

• 49660-56-2 8-methylchroman-4-one 
• 13630-45-0 3-o-Tolyloxy-propionsaeure-vinylester 
• 64381-14-2 3-o-Tolyloxy-propionic acid (2-chloro-phenoxycarbonylamino)-methyl ester 
• 64381-09-5 3-o-Tolyloxy-propionic acid (naphthalen-1-yloxycarbonylamino)-methyl ester 
• 64381-22-2 3-o-Tolyloxy-propionic acid (2,4-dichloro-phenoxycarbonylamino)-methyl ester 
• 64381-30-2 3-o-Tolyloxy-propionic acid (2,6-dichloro-phenoxycarbonylamino)-methyl ester 
• 64381-35-7 3-o-Tolyloxy-propionic acid (3,5-dimethyl-4-methylsulfanyl-phenoxycarbonylamino)-methyl ester 
• 90921-10-1 acide chromannone-4 carboxylique-8 
• 65017-39-2 8-methyl-4H-1-benzopyran-4-one 
• 3722-72-3 8-methyl-chroman 
• 90918-59-5 3-<2-Carbamoyl-phenoxy>-propionamid 
• 92865-29-7 3-<2-Aethoxycarbonyl-phenoxy>-propionsaeure-aethylester 

Relevant articles and documents

Acid activated montmorillonite K-10 mediated intramolecular acylation: Simple and convenient synthesis of 4-chromanones

3-Aryloxyproionic acids undergo intramolecular cyclization in the presence of AA.Mont.K-10 in toluene under reflux for 30–45 min in good to excellent yields. Phenyl ring bearing various substituents at the ortho, meta, para positions undergo this cyclization reaction. This method involves simple work up and amenable for large scale preparations. The heterogeneous acid treated catalyst can be regenerated and used for up to three cycles with minimum loss of activity.

Efficient and rapid synthesis of phenolic analogs of 4-phenylbutanoic acid using microwave-assisted Michael addition as a key reaction

ABSTRACT: The addition of phenols to acrylonitrile in the presence of aqueous benzyltrimethylammonium hydroxide or tetramethylammonium hydroxide under microwave irradiation yielded the corresponding Michael adducts. The obtained adducts were easily transformed to phenolic analogs of 4-phenylbutanoic acids via the hydrolysis of nitrile groups.

SYNTHESIS OF PROPYL PHENOXY ETHERS AND USE AS DELIVERY AGENTS

The present invention provides propyl phenoxy ether compounds and pharmaceutically acceptable salts thereof, compositions containing the same and one or more active agents, and methods of administering active agents with the same. The delivery agents of the present invention are well suited for forming non-covalent mixtures with active agents for oral, iπtracolonic, pulmonary, and other routes of administration to animals.